This is the first study to show a clear benefit of GLP-1 receptor agonists on kidney failure or end-stage kidney disease, suggesting they have a key role in kidney-protective and heart-protective treatment for patients with common medical conditions like type 2 diabetes, overweight or obesity with cardiovascular disease, or CKD [chronic kidney disease], said lead author Sunil Badve, professorial fellow at The George Institute for Global Health and UNSW Sydney
GSH transport in human cerebrovascular endothelial cells and human astrocytes: evidence for luminal localization of Na+-dependent GSH transport in HCEC
Research has shown that glutathione and Vitamin C are best friends
These livers are usually coarsely scarred with variably thick and thin septa and may be either normal or reduced in size
Read the full press release: #BioNxt #HealthcareInnovation #DrugDelivery #Semaglutide BioNxt Solutions Post PRESS RELEASE: BioNxt Solutions announces the development of a sublingual thin-film technology for Semaglutide, a widely used therapeutic for Type 2 diabetes and obesity
Managing weight can be a significant challenge, particularly for men who face unique health challenges related to obesity